Oric Pharmaceuticals, Inc. Common Stock
$12.54
$0.18 (+1.46%)
$12.17Day Range$12.84
Key Statistics
Market Cap
$1.28B
Shares Outstanding
103.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 24, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$12.38
Day High
$12.84
Day Low
$12.17
Volume
1.61M
VWAP
$12.55
Prev Close
$12.36
Transactions
--
Acc. Volume
--
About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
PHARMACEUTICAL PREPARATIONSSIC 2834111 employees240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA, 94080(650) 388-5600IPO Apr 24, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001796280
- Composite FIGI
- BBG00BL5SLH5
- Share Class FIGI
- BBG00BL5SMR2
- Ticker Root
- ORIC
- SIC Code
- 2834
About Oric Pharmaceuticals, Inc. Common Stock (ORIC) Stock
Oric Pharmaceuticals, Inc. Common Stock (ORIC) closed the 2026-09-16 session at $12.54, up 1.46% versus the previous close (+0.18). The stock opened at $12.38 and traded between $12.17 and $12.84 during that session. Session trading volume was 1.6M shares. The volume-weighted average price (VWAP) is $12.55.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Oric Pharmaceuticals, Inc. Common Stock has a market capitalization of $1.28 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ORIC is listed on the XNAS exchange. The company employs approximately 111 people. Oric Pharmaceuticals, Inc. Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2020-04-24.
On this page you can find market ORIC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.